Add-on Acquisition • Life Science

Headlands Research Acquires JEM Research Institute

On July 7, 2020, Headlands Research acquired life science company JEM Research Institute

Acquisition Context
  • This is Headlands Research’s 1st transaction in the Life Science sector.
  • This is Headlands Research’s 1st transaction in the United States.
  • This is Headlands Research’s 1st transaction in Florida.

Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free


M&A Deal Summary

Date July 7, 2020
Target JEM Research Institute
Sector Life Science
Buyer(s) Headlands Research
Deal Type Add-on Acquisition

Target Company

JEM Research Institute

Lake Worth, Florida, United States
Founded in 2007 and located in Lake Worth, Florida, JEM Research Institute is a leading CNS research center. The JEM Research Institute physicians have conducted over 200 clinical trials, with a primary focus in CNS. JEM’s 9,500 square foot dedicated research facility boasts over 10 exam rooms, an administrative office suite, and a large patient infusion suite that can accommodate physicians, subjects, and monitors with maximum efficiency and safety. Its founders, Drs. Mark Goldstein and James Goldenberg, the latter of whom is on the Board of Directors of the American Academy of Neurology, are neurologists and highly-regarded key opinion leaders in the neurology field.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

Headlands Research

Lake Worth, Florida, United States

Category Company
Founded 2018
Sector Life Science
DESCRIPTION

Headlands Research is a multinational integrated clinical trial site organization with a mission to improve lives by advancing innovative medical therapies. Headlands Research was formed in 2018 and is based in Lake Worth, Florida.


Deal Context for Buyer #
Overall 2 of 9
Sector: Life Science 1 of 7
Type: Add-on Acquisition 2 of 9
State: Florida 1 of 1
Country: United States 1 of 7
Year: 2020 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-07-07 Toronto Memory Program

Toronto, Ontario, Canada

Founded in 1996 by Drs. Sharon and Ian Cohen, Toronto Memory Program is a community-based clinical trial facility specializing in interventional trials for Alzheimer’s disease and related disorders. The research facility adjoins the largest memory clinic for the diagnosis and clinical care of Alzheimer’s disease and dementia in Canada. Toronto Memory Program has completed over 150 CNS trials since its inception, bringing important Alzheimer’s disease trial opportunities to patients within Canada. In the past year, Dr. Sharon Cohen has been featured on multiple Sponsor panels to announce important drug development milestones, and her work with Alzheimer’s disease has been highlighted in The New York Times.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-05-13 Summit Research Network

Portland, Oregon, United States

Summit Research Network provides medical treatment by conducting high-quality scientific research and patient care. Summit Research Network specializes in the areas of psychiatry, dementia, and other age-related memory conditions such as Alzheimer’s and Lewy Bodies, and operates a specialized Memory Health Center. Summit Research Network was founded in 1976 and is based in Portland, Oregon.

Buy -